Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting β-III-spectrin

Robyn T. Rebbeck, Anna K. Andrick, Sarah A. Denha, Bengt Svensson, Piyali Guhathakurta, David D. Thomas, Thomas S. Hays, Adam W. Avery

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting β-III-spectrin'. Together they form a unique fingerprint.

Chemistry

Biochemistry, Genetics and Molecular Biology

Neuroscience